ENTITY

Imunon (IMNN US)

22
Analysis
Health Care • United States
IMUNON, Inc. operates as a clinical stage biotechnology company. The Company focuses on advancing a portfolio of innovative treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON serves customers worldwide.
more
Company Event • 13 Nov 2026 00:00 • Upcoming
Add To Calendar

Q3 2026

Company Event • 23 Sep 2026 22:00 • Latest

R&D Day 2026

Company Event • 11 Aug 2026 23:00

Q2 2026

Company Event • 07 Jul 2026 00:00 • Upcoming
Add To Calendar

Investor presentation

Company Event • 26 Jun 2026 00:00

Life Sciences Virtual Investor Forum

x